Editorial: Exploring SARS-CoV-2 inflammatory responses and potential targets for treatment

Editorial: Exploring SARS-CoV-2 inflammatory responses and potential targets for treatment

Saved in:

Bibliographic Details
Main Authors:	Kanchan Bhardwaj, Kuan Rong Chan
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-05-01
Series:	Frontiers in Cellular and Infection Microbiology
Subjects:	COVID-19 SARS-CoV-2 IFIT3 antiviral dysregulated immune response
Online Access:	https://www.frontiersin.org/articles/10.3389/fcimb.2025.1625563/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A Novel Toolkit of SARS-CoV-2 Sub-Genomic Replicons for Efficient Antiviral Screening
by: Maximilian Erdmann, et al.
Published: (2025-04-01)

Antiviral efficacy of silicon nitride against SARS-CoV-2 and MERS-CoV: implications for PPE innovation
by: Brittany N. Heath, et al.
Published: (2025-08-01)

A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2
by: Alexander Simonis, et al.
Published: (2020-11-01)

Evolution of Antiviral Drug Resistance in SARS-CoV-2
by: Roy Dinata, et al.
Published: (2025-05-01)

Advancements in the development of antivirals against SARS-Coronavirus
by: Mrityunjay Kumar, et al.
Published: (2025-01-01)

Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated
by: Delma J. Nieves, et al.
Published: (2025-03-01)

Characterization of Nanobody Binding to Distinct Regions of the SARS-CoV-2 Spike Protein by Flow Virometry
by: Mariam Maltseva, et al.
Published: (2025-04-01)

Is Autophagy a Friend or Foe in SARS-CoV-2 Infection?
by: Asifa Khan, et al.
Published: (2024-09-01)

Assessing multi-target antiviral and antioxidant activities of natural compounds against SARS-CoV-2: an integrated in vitro and in silico study
by: Aisha Nawaf Al balawi, et al.
Published: (2024-11-01)

Targeting CTP synthetase 1 to restore interferon induction and impede nucleotide synthesis in SARS-CoV-2 infection
by: Youliang Rao, et al.
Published: (2025-06-01)

SARS-CoV-2 drug resistance and therapeutic approaches
by: Sania Batool, et al.
Published: (2025-01-01)

Aerosol and surface persistence: Novel SARS-CoV-2 versus other coronaviruses
by: Kewal Krishan, et al.
Published: (2020-07-01)

The Ability of Combined Flavonol and Trihydroxyorganic Acid to Suppress SARS-CoV-2 Reproduction
by: Andrey Bogoyavlenskiy, et al.
Published: (2024-12-01)

Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication
by: Jerneja Kladnik, et al.
Published: (2022-12-01)

Kaurenoic acid is a potent inhibitor of SARS-CoV-2 RNA synthesis, virion assembly, and release in vitro
by: Igor Andrade Santos, et al.
Published: (2025-05-01)

Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
by: Kuoyuan Cheng, et al.
Published: (2021-10-01)

Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses
by: Valeria Fumagalli, et al.
Published: (2023-03-01)

An Assessment of the Efficacy of Commercial Air Ionizer Systems Against a SARS-CoV-2 Surrogate
by: Nachiket Vaze, et al.
Published: (2025-03-01)

SARS-CoV-2 and Coronaviruses: Understanding Transmission, Impact, and Strategies for Prevention and Treatment
by: Seyede Nafise Tabatabaei, et al.
Published: (2025-02-01)

Taurultam shows antiviral activity against SARS-CoV-2 and influenza virus
by: Rongbo Luo, et al.
Published: (2025-05-01)

Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage
by: Changqing Yu, et al.
Published: (2023-12-01)

Gemcitabine, lycorine and oxysophoridine inhibit novel coronavirus (SARS-CoV-2) in cell culture
by: Ya-Nan Zhang, et al.
Published: (2020-01-01)

EIDD-2801 resists to infection and co-infection of SARS-CoV-2 and influenza virus
by: Bingshuo Qian, et al.
Published: (2025-04-01)

Is The SARS-CoV2 Evolved in Human Being: A prospective Genetic Analysis
by: Salvatore Dimonte, et al.
Published: (2020-12-01)

Cellular Receptor Tyrosine Kinase Signaling Plays Important Roles in SARS-CoV-2 Infection
by: Shania Sanchez, et al.
Published: (2025-03-01)

Interaction of SARS-CoV-2 and SARS-CoV-2 vaccines with renin angiotensin aldosterone system, clinical outcomes, and angiotensin (1-7) as a physiological treatment recommendation: hypothesis and theory article
by: Ali Rıza Aktaş
Published: (2025-07-01)

SARS-CoV-2 genomic evolution during a severe and long-lasting omicron infection under antiviral therapy
by: Matteo Bolis, et al.
Published: (2025-03-01)

Clinical Utility of IFIT Proteins in Human Malignancies
by: Armen Parsyan, et al.
Published: (2025-06-01)

Genomic surveillance of SARS-CoV-2 variants using pooled WGS
by: Inho Park, et al.
Published: (2025-04-01)

Protective Potential and Functional Role of Antibodies Against SARS-CoV-2 Nucleocapsid Protein
by: Alexandra Rak, et al.
Published: (2025-05-01)

SARS-CoV-2 associated encephalitis
by: Jasmina Poluga, et al.
Published: (2025-05-01)

In silico exploration of binding potentials of anti SARS-CoV-1 phytochemicals against main protease of SARS-CoV-2
by: Abdullah G. Al-Sehemi, et al.
Published: (2022-05-01)

Real-world cost-effectiveness of nirmatrelvir-ritonavir as treatment for SARS-CoV-2 infection in the Belgian setting with omicron variant
by: Sophie Marbaix, et al.
Published: (2025-02-01)

Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
by: Vahid Rajabali Zadeh, et al.
Published: (2025-05-01)

An ACE2-Fc decoy produced in glycoengineered plants neutralizes ancestral and newly emerging SARS-CoV-2 variants and demonstrates therapeutic efficacy in hamsters
by: Esther Föderl-Höbenreich, et al.
Published: (2025-04-01)

Computational Insights into Acrylamide Fragment Inhibition of SARS-CoV-2 Main Protease
by: Ping Chen, et al.
Published: (2024-11-01)

Antimalarial compounds exhibit variant- and cell-type-specific activity against SARS-CoV-2 isolated in Panama
by: Mario Quijada, et al.
Published: (2025-06-01)

A rare case of macroamylasemia in a patient with SARS-CoV-2 infection
by: Tilan Aponso, et al.
Published: (2025-02-01)

Structural basis for varying drug resistance of SARS-CoV-2 Mpro E166 variants
by: Morgan A. Esler, et al.
Published: (2025-07-01)

Glycosylated Receptor-Binding-Domain-Targeting Mucosal Vaccines Protect Against SARS-CoV-2 Omicron and MERS-CoV
by: Xiaoqing Guan, et al.
Published: (2025-03-01)